Implementing an Intensified Dynamic Perfusion Process for Biologics Manufacturing at Scale and Continued Development.
Perfusion cell culture is increasingly adopted to improve productivity, reduce footprint, and enable integrated continuous bioprocessing. The high-intensity, low-volume perfusion (HILVOP) process for antibody production was implemented at both 100 L pilot and 500 L manufacturing scales for early clinical supply, and de...